BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 15847669)

  • 1. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
    Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
    Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
    Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
    Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
    Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
    Shaw BE; Russell NH; Devereux S; Das-Gupta E; Mackinnon S; Madrigal JA; Pagliuca A; Mufti GJ; Byrne JL
    Haematologica; 2005 Nov; 90(11):1562-9. PubMed ID: 16266905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
    Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
    Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
    Klumpp TR; Herman JH; Ulicny J; Emmons RV; Martin ME; Mangan KF
    Bone Marrow Transplant; 2006 Nov; 38(9):615-20. PubMed ID: 16964267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.
    Remberger M; Watz E; Ringdén O; Mattsson J; Shanwell A; Wikman A
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):675-82. PubMed ID: 17531777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
    Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A
    Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
    Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
    Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.